Division of Nephrology

Scott Brimble

MD, BScH, MSc

Assocaite Professor, Division of Nephrology, Department of Medicine

Medical Director, SJH Peritoneal Dialysis Program

Internal Medicine Clerkship Coordinator, Physician's Assistants Program

 

 

 

Education and Professional Standing

  • MD (Toronto) 1996
  • Internal Medicine (McMaster) 2000
  • Nephrology (McMaster) 2001
  • PhD Human Biodynamics, enrolled (McMaster University)

Training

  • BScH, Msc Biological Sciences (Brock University) 1990
  • MD (Toronto) 1996
  • Internal Medicine (McMaster) 2000
  • Nephrology (McMaster) 2001
  • PhD Human Biodynamics , enrolled (McMaster University)

Administrative responsibilities

  • Medical Director, SJH Peritoneal Dialysis Program
  • Internal Medicine Clerkship Coordinator, Physician's Assistants Program

Clinical interests

  • Chronic Kidney Disease
  • Dialysis
  • Hypertension

Research Interests

  • Solute transport in peritoneal dialysis
  • Fluid management in ESRD
  • Skeletal muscle abnormalities in patients with chronic kidney disease
  • Anemia in chronic kidney disease

Outside interests

  • trail-running
  • road and mountain biking
  • family

Publications Last 5 Years

  1. Brimble KS, McFarlane AG, Winegard AJ, Crowther MJ, Churchill DN. Effect of uremia and hemodialysis on red blood cell aggregation and deformability, Clin Hemorheol Microcirc 34:411-20, 2006
  2. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. Thromb Res 118: 397-407, 2006
  3. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17:2591-8, 2006.
  4. Margetts PJ, Brimble S. Peritoneal dialysis, membranes, and beyond. Curr Opin Nephrol Hypertens 15: 571-6, 2006
  5. Brimble KS, Clase CM. Hemoglobin variability in dialysis patients. J Am Soc Nephrol 18: 2218-20, 2007.
  6. Gangji AS, Helal BA, Churchill DN, Brimble KS, Margetts PJ. Association between N-terminal propeptide B-type natriuretic peptide and markers of hypervolemia. Perit Dial Int 28: 308-311, 2008.
  7. Gangji AS, Brimble KS, Margetts PJ. Association between markers of inflammation, fibrosis, and hypervolemia in peritoneal dialysis patients. Blood Purif 28: 354-8, 2009.
  8. Lau JH, Gangji AS, Rabbat CG, Brimble KS. Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial. Nephrol Dial Transplant 25: 4002-9, 2010.
  9. Su WS, Clase CM, Brimble KS, Margetts PJ, Wilkieson TJ, Gangji AS. Waist-to-Hip Ratio, Cardiovascular Outcomes, and Death in Peritoneal Dialysis Patients. Int J Nephrol vol. 2010, Article ID 831243, 5 pages.
  10. Su WS, Gangji AS, Margetts PM, Ganame J, Noseworthy M, Bosch J, Lonn E, Yusuf S, Jain AK, Brimble KS. The FLUID study protocol: a randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients. Per Dial Int, accepted.